SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-026436
Filing Date
2024-11-08
Accepted
2024-11-08 16:18:23
Documents
2
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 form3-11082024_091119.html 3  
1 form3-11082024_091119.xml 3 1694
2 ex24-11082024_091119.htm EX-24 6708
  Complete submission text file 0001415889-24-026436.txt   9803
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SCHOLAR ROCK 620 MEMORIAL DR., 2ND FLOOR CAMBRIDGE MA 02139
Business Address
CHYUNG YUNG H. (Reporting) CIK: 0001740377 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39264 | Film No.: 241440875